| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | 3-dioxygenase ELISA Kit; I23O1_HUMAN ELISA Kit; IDO 1 ELISA Kit; IDO ELISA Kit; IDO-1 ELISA Kit; IDO1 ELISA Kit; INDO ELISA Kit; indolamine 2,3 dioxygenase ELISA Kit; Indole 2 3 dioxygenase ELISA Kit; indoleamine 2 3 dioxygenase 1 ELISA Kit; indoleamine 2 3 dioxygenase ELISA Kit; Indoleamine 2,3-dioxygenase 1 ELISA Kit; Indoleamine pyrrole 2 3 dioxygenase ELISA Kit; Indoleamine-pyrrole 2 ELISA Kit |
| Assay Time | |
| Assay Type | |
| Detection Range | |
| Detection Wavelength | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | serum, plasma, tissue homogenates, cell lysates |
| Sensitivity | |
| Species | |
| Target | |
| UniProt # |
Background
indoleamine 2, 3-dioxygenase (IDO1) is a biological molecule commonly studied in metabolism research. It is commonly used as a molecular readout in mechanistic and biomarker-focused studies.
UniProt: P14902
Biological context
Researchers often monitor indoleamine 2, 3-dioxygenase in serum, plasma, tissue homogenates, and cell lysates to better understand themes such as energy homeostasis, glucose and lipid metabolism, and insulin sensitivity and endocrine regulation. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in indoleamine 2, 3-dioxygenase may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, insulin, adipokines, lipid-transport proteins, and stress-related enzymes) and by keeping pre-analytical variables consistent across groups.
Nomenclature
In publications and databases, indoleamine 2, 3-dioxygenase may also appear under names such as 3-dioxygenase and I23O1_HUMAN. When comparing studies, confirm that the reported analyte refers to the same molecule and species context.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that indoleamine 2, 3-dioxygenase participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Indoleamine-2,3-Dioxygenase 1 (IDO1) Deciency Attenuates Spontaneous Recurrent Seizures (SRS) after Status Epilepticus(SE) in the LithiumPilocarpine Model of Epilepsy
N Deng,Research Square,2020
Correlations of indoleamine 2,3-dioxygenase, interferon-λ3, and anti-HBs antibodies in hemodialysis patients
Alicja E.Grzegorzewska.et al,Vaccine,2018
Indoleamine 2, 3-dioxygenase (IDO) levels in leprosy patients with positive serology
Ago Harlim.et al,Journal of Pakistan Association of Dermatologists,2017
Serum levels and activity of indoleamine2, 3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney
Bao YS et al,Biomarkers,2013
Plasma indoleamine 2, 3-dioxygenase and arginase type IMay contribute toDecreased blood T-cell count in hemodialysis patients
Eleftheriadis T et al,Ren Fail,2012
Indoleamine 2, 3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination
/,Vaccine,2011